58
Participants
Start Date
August 22, 2008
Primary Completion Date
April 20, 2012
Study Completion Date
April 20, 2012
Everolimus
Everolimus tablets
New York University Medical Center NYU Cancer Institute, New York
Western Pennsylvania Cancer Institute /Western Penn Hospital Western Pann. Cancer Inst., Pittsburgh
University of Pittsburgh Medical Center Hillman Cancer Center (4), Pittsburgh
West Virginia University/ Mary Babb Randolph Cancer Center, Morgantown
East Carolina University BrodySchool of Medicine, Greenville
Cancer Centers of the Carolinas CC of C -Eastside, Greenville
Georgia Health Sciences University Dept. of MCG, Augusta
Advanced Medical Specialties Medical Onc Hem, Miami
Vanderbilt University Medical Center, Clinical Trials Center Dept. of VUMC, Nashville
St. Francis Cancer Research Foundation Dept.ofSt.FrancisCancerRes.(2), Beech Grove
Central Indiana Cancer Centers CICC - East (2), Indianapolis
Mayo Clinic - Rochester Hematology, Rochester
Northwestern University, Chicago
Washington University School Of Medicine-Siteman Cancer Ctr Medical Oncology, St Louis
Highlands Oncology Group DeptofHighlandsOncologyGrp(2), Fayetteville
Baylor College of Medicine Dept. of Sammons Cancer (2), Dallas
Tyler Cancer Center Dept.ofTylerCancerCtr., Tyler
Rocky Mountain Cancer Centers RMCC - Denver-Midtown, Greenwood Village
Mayo Clinic - Arizona Mayo Clinic - Scottsdale, Multiple Locations
UCLA/ University of California Los Angeles Dept.of Hem/Oncology, Los Angeles
Bay Area Cancer Research Dept.ofBayAreaCancerResearch, Concord
University of California Davis Cancer Center Dept. of UC Davis Cancer (4), Sacramento
Northwest Cancer Specialists Vancouver Cancer Center (2), Portland
Kaiser Permanente Northwest Dept of Kaiser Northwest (3), Portland
Cancer Care Northwest CC Northwest- Spokane South(3), Spokane
City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1), Duarte
University of Michigan Comprehensive Cancer Center Dept of Michigan Cancer Center, Ann Arbor
Hackensack University Medical Center Dept ofHackensackUniversityMC, Hackensack
Fox Chase Cancer Center Regulatory Contact, Philadelphia
University of Texas Southwestern Medical Center DeptofSimmons Cancer Center(2), Dallas
MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (10), Houston
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY